In just a few short years, digital therapeutics (DTx) have become an exciting, incredibly competitive new frontier in healthcare. DTx deliver evidence-based therapeutic interventions to patients via software applications, and are meant to prevent, manage, or treat a broad spectrum of physical, mental, and behavioral conditions. Often touted to be just as clinically effective as pharmaceuticals, DTx development costs are significantly less than typical pharmaceuticals, which usually take billions to bring to market.

Download Digest